Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold

Org Biomol Chem. 2016 Feb 14;14(6):2052-6. doi: 10.1039/c5ob02016f.

Abstract

Recognition of RNA by high-affinity binding small molecules is crucial for expanding existing approaches in RNA recognition, and for the development of novel RNA binding drugs. A novel neomycin dimer benzimidazole conjugate 5 (DPA 83) was synthesized by conjugating a neomycin-dimer with a benzimidazole alkyne using click chemistry to target multiple binding sites on HIV TAR RNA. Ligand 5 significantly enhances the thermal stability of HIV TAR RNA and interacts stoichiometrically with HIV TAR RNA with a low nanomolar affinity. 5 displayed enhanced binding compared to its individual building blocks including the neomycin dimer azide and benzimidazole alkyne. In essence, a high affinity multivalent ligand was designed and synthesized to target HIV TAR RNA.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aminoglycosides / chemical synthesis
  • Aminoglycosides / chemistry
  • Aminoglycosides / pharmacology*
  • Benzimidazoles / chemical synthesis
  • Benzimidazoles / chemistry
  • Benzimidazoles / pharmacology*
  • Binding Sites / drug effects
  • Click Chemistry
  • Dose-Response Relationship, Drug
  • HIV Long Terminal Repeat / drug effects*
  • Ligands
  • Molecular Conformation
  • Neomycin / chemistry
  • Neomycin / pharmacology
  • RNA, Viral / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Aminoglycosides
  • Benzimidazoles
  • Ligands
  • RNA, Viral
  • benzimidazole
  • Neomycin